Table 8:
Aneurysm (re)-bleeding summary
| Case/Sex/Age | Presentation | Use of Antiplatelet | Initial Aneurysm Occlusion | Stent | (Re)-Bleeding Delay | Outcome (mRS) |
|---|---|---|---|---|---|---|
| 1/F/71 | SAH | None | 1 | None | Day 1 | 6 |
| 2/F/68 | Fortuitous | None | 1 | None | 12 mo | 4 |
| 3/M/46 | SAH | None | 3 | None | Day 10 | 6 |
| 4/F/48 | SAH | None | 3 | None | Day 10 | 6 |
| 5/F/65 | SAH | 8 mg i.a. of abciximab during procedure | 1 | None | Hour 14 | 6 |
| 6/F/57 | SAH | None | 1 | None | Day 1 | 4 |
| 7/M/35 | SAH | None | 1 | None | Hour 6 | 6 |
| 8/M/48 | SAH | None | 3 | None | Hour 8 | 6 |
| 9/F/55 | SAH | None | 3 | None | 89 mo | 6 |
| 10/F/37 | SAH | None | 2 | None | 57 mo | 6 |
| 11/F/52 | SAH | None | 1 | None | 17 mo | 1 |
| 12/F/81 | SAH | None | 3 | None | Day 4 | 6 |
| 13/F/55 | SAH | None | 3 | None | 4 mo | 6 |
| 14/M/52 | Fortuitous | Clopidogrel + aspirin | 2 | Yes | 12 mo | 1 |
| 15/M/41 | SAH | None | 1 | None | Day 18 | 6 |
| 16/M/52 | SAH | 4 mg i.a. of abciximab during procedure | 1 | None | Day 1 | 6 |
| 17/F/51 | SAH | 4 mg i.a. of abciximab during procedure | 1 | None | Hour 4 | 6 |
| 18/M/20 | SAH | No | 1 | None | Day 22 | 1 |
| 19/M/69 | Fortuitous | Clopidogrel + aspirin | 1 | Yes | Day 21 | 6 |
| 20/F/56 | SAH | No | 3 | None | Day 1 | 6 |
| 21/F/56 | SAH | No | 3 | None | 2 mo | 1 |
Note:—i.a. indicates intra-arterial.